Alvina D. Chu
- Dermatology top 0.2%
- Rheumatology top 1%
- Immunology and Allergy top 0.5%
- Immunology top 5%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Henrique D. TeixeiraJohn LiuBarry LadizinskiEric L. SimpsonAndrew BlauveltMarjolein de Bruin‐WellerXiaofei HuAileen L. Pangan
- Topics
- Chronic Lymphocytic Leukemia Research (13 papers)Dermatology and Skin Diseases (13 papers)Lymphoma Diagnosis and Treatment (10 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Alvina D. Chu
33 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 72
- Dermatology 1.1k
- Rheumatology 842
- Immunology and Allergy 729
- Immunology 728
- Pathology and Forensic Medicine 437
Countries citing papers authored by Alvina D. Chu
This map shows the geographic impact of Alvina D. Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alvina D. Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alvina D. Chu more than expected).
Fields of papers citing papers by Alvina D. Chu
This network shows the impact of papers produced by Alvina D. Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alvina D. Chu. The network helps show where Alvina D. Chu may publish in the future.
Co-authorship network of co-authors of Alvina D. Chu
This figure shows the co-authorship network connecting the top 25 collaborators of Alvina D. Chu. A scholar is included among the top collaborators of Alvina D. Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alvina D. Chu. Alvina D. Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 17 | |
| 3 | 10 | |
| 4 | 43 | |
| 5 | 76 | |
| 6 | Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trialbreakdown → | 250 |
| 7 | Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsbreakdown → | 350 |
| 8 | 41 | |
| 9 | 242 | |
| 10 | 32 | |
| 11 | 1 | |
| 12 | 65 | |
| 13 | 8 | |
| 14 | 23 | |
| 15 | 127 | |
| 16 | 1 | |
| 17 | 33 | |
| 18 | 50 | |
| 19 | 21 | |
| 20 | 75 |
About Alvina D. Chu
Alvina D. Chu is a scholar working on Immunology and Allergy, Dermatology and Genetics, having authored 34 papers that have together received 2.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (13 papers), Dermatology and Skin Diseases (13 papers) and Lymphoma Diagnosis and Treatment (10 papers). The work is most often cited by research in Dermatology (1.1k citations), Immunology and Allergy (729 citations) and Rheumatology (842 citations). Alvina D. Chu has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Henrique D. Teixeira, John Liu, Barry Ladizinski, Eric L. Simpson, Andrew Blauvelt, Marjolein de Bruin‐Weller, Xiaofei Hu, Aileen L. Pangan, Antonio Costanzo and Norito Katoh. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.